XML 44 R16.htm IDEA: XBRL DOCUMENT
v3.25.2

Stockholders’ Deficit | 6 Months Ended
--- | ---
Jun. 30, 2025
Equity [Abstract] |
Stockholders’ Deficit | Note 8 – Stockholders’ Deficit Change in Authorized Shares On June 14, 2024, the Company’s Board of Directors approved an increase in authorized common stock from 50,000,000 to 500,000,000 shares. This increase was made to:
| ● | Support current and future equity financings,
| ● | Facilitate conversions of preferred stock into common stock,
| ● | Enable future stock-based compensation plans, and
| ● | Provide flexibility for potential mergers, acquisitions, and other corporate transactions.
As of June 30, 2025, the Company had four classes of stock, detailed as follows: Preferred Stock The Company’s undesignated preferred stock provides flexibility for future corporate financing and strategic transactions.
| ● | Authorized Shares: 5,000,000
| ● | Issued & Outstanding: None
| ● | Par Value: $0.0001 per share
| ● | Voting Rights: None
| ● | Ranking: Senior to all other classes of stock, including Series A and Series B convertible preferred stock, unless otherwise designated
| ● | Dividends: None, unless declared by the Board of Directors
| ● | Liquidation Preference: None
| ● | Redemption Rights: None
| ● | Conversion Rights: None
The Board of Directors has the authority to issue preferred stock in one or more series and determine the rights, privileges, and restrictions of each series without further stockholder approval. Convertible Preferred Stock – Series A On August 16, 2024, the Company designated and issued Series A convertible preferred stock as part of a debt-to-equity conversion.
| ● | Authorized Shares: 513,000
| ● | Issued & Outstanding: 363,000 shares as of June 30, 2025 and December 31, 2024, respectively
| ● | Par Value: $0.0001 per share
| ● | Stated Value: $10 per share
| ● | Conversion Terms:
| ○ | Fixed conversion rate: 4.53 shares of common stock per Series A convertible preferred stock
| ○ | Conversion price:
| ■ | Calculated as $10 per share ÷ 80% of the minimum trading price at issuance ($2.21 per share)
| ■ | Results in a fixed number of common shares per preferred share
| ○ | Total equivalent common shares at June 30, 2025 and December 31, 2024 were 1,644,022, respectively
| ○ | No variable number of shares are required for settlement
| ● | Dividend Provisions:
| ○ | Rate: 10% per year (2.5% per quarter), accrued and payable in common stock
| ○ | Calculation:
| ■ | Shares issued × Stated value × Dividend percentage ÷ Fixed conversion price ($2.21/share)
| ○ | No potential dilution beyond the fixed conversion amount
| ● | Voting Rights: Equal to the number of converted common shares
| ● | Liquidation Preference: None
| ● | Redemption Rights: None
| ● | Derivative Liability Assessment:
| ○ | Evaluated under ASC 815 (“Derivatives and Hedging”)
| ○ | The Series A convertible preferred stock does not meet the definition of a derivative liability since its conversion feature is fixed and does not require a variable number of settlement shares.
Convertible Preferred Stock – Series B On October 1, 2024, the Company designated and issued Series B convertible preferred stock as part of a structured financing transaction.
| ● | Authorized Shares: 150,000
| ● | Issued & Outstanding: 140,000 shares as of June 30, 2025 and December 31, 2024, respectively
| ● | Par Value: $0.0001 per share
| ● | Stated Value: $10 per share
| ● | Conversion Terms:
| ○ | Fixed conversion rate: 5.18 shares of common stock per Series B convertible preferred stock
| ○ | Conversion price:
| ■ | Calculated as $10 per share ÷ 70% of the minimum trading price at issuance ($1.93 per share)
| ■ | Results in a fixed number of common shares per preferred share
| ○ | Total equivalent common shares at June 30, 2025 and December 31, 2024 were 724,638, respectively
| ○ | No variable number of shares are required for settlement
| ● | Dividend Provisions:
| ○ | Rate: 12% per year (3% per quarter), accrued and payable in common stock
| ○ | Calculation:
| ■ | Shares issued × Stated value × Dividend percentage ÷ Fixed conversion price ($1.93/share)
| ○ | No potential dilution beyond the fixed conversion amount
| ● | Voting Rights: Equal to the number of converted common shares
| ● | Liquidation Preference: None
| ● | Redemption Rights: None
| ● | Derivative Liability Assessment:
| ○ | Evaluated under ASC 815
| ○ | The Series B convertible preferred stock does not meet the definition of a derivative liability due to its fixed conversion price.
Common Stock
| ● | Authorized Shares: 500,000,000
| ● | Issued & Outstanding*:
| ○ | 122,051,560 shares as of June 30, 2025
| ○ | 2,756,508 shares as of December 31, 2024
| ● | Par Value: $0.0001 per share
| ● | Voting Rights: 1 vote per share
| ● | Dividends: None
*In connection with the common control merger, any shares issued to Next Holding, an entity under common control, are excluded from the total shares outstanding. This is because, under U.S. GAAP, a company cannot recognize an investment in itself. Accordingly, these shares are treated as constructively retired or held by the Company as treasury stock equivalent and are not considered outstanding for earnings per share or equity reporting purposes. Under ASC 810-10-45-1 and ASC 505-10-45-2, equity interests held by a parent, subsidiary, or an entity under common control in the reporting entity must be eliminated in consolidation. Similarly, shares held by entities consolidated into or controlled by the Company are treated as not outstanding, since they represent an indirect investment in the Company’s own equity. Securities and Incentive Plans The Company maintains stock-based compensation plans under which stock options, restricted stock, and other equity awards are granted to employees, directors, and consultants. Equity Transactions for the Six Months Ended June 30, 2025 Stock Issued for Cash and Warrants – Public Offering On February 18, 2025, the Company sold 5,000,000 shares of common stock for gross proceeds of $15,000,000 ($3/share). In connection with this offering, the Company paid direct offering costs of $1,538,914, resulting in net proceeds of $13,461,086. The proceeds from the offering are expected to be used for:
| ● | Expanding operations and infrastructure;
| ● | Repaying outstanding debt; and
| ● | Funding general corporate purposes, including working capital requirements
Additionally, the Company granted the underwriter the option to purchase up to 750,000 additional over-allotment shares of common stock at $3/share, for a period of 45 days (through March 3, 2025). In connection with this option, the Company issued an additional 75,378 shares of common stock for gross proceeds of $226,134 ($3/share). In connection with this offering, the Company paid direct offering costs of $18,091, resulting in net proceeds of $208,043. The underwriter was also issued 250,000 warrants for services rendered in connection with the offering, which will be accounted for as a direct offering cost. These warrants are exercisable at $3.75/share. These warrants are exercisable beginning 6 months after the grant date and for an additional 4.5 years through February 13, 2030. Stock Issued for Services The Company issued 7,336,821 shares of common stock to consultants for services rendered, having a fair value of $21,326,731 ($2.57 - $3.90/share), based upon the quoted closing trading price. Additionally, the Company issued 1,889,002 shares of common stock to consultants for prepaid services, having a fair value of $5,623,425 ($2.91 - $3.21/share), based upon the quoted closing trading price. Stock Issued as Loan Extension Fee In connection with the extension of loan #5, the Company was required to pay a fee of $150,000 in common stock. The Company issued 41,437 shares of common stock ($3.62/share) and recorded additional interest expense. In connection with the extension of loan #12, the Company was required to pay a fee of 116,000 shares of common stock with a fair value of $347,960 ($2.91 - $3.31/share) based upon the quoted closing trading price. Stock Issued for Conversion of Accounts Payable The Company issued 22,013 shares with a fair value of $68,681 ($3.12/share) to a vendor to settle accounts payable of $40,000, resulting in a loss on settlement of liabilities of $28,681. Stock Issued for Conversion of Notes Payable The Company issued 256,667 shares of common stock to convert the remaining balance of $770,000 on loan #17 at a price per share of $3.00 or fair value of $770,000. The Company issued 550,000 shares of common stock to convert the flat-rate interest owed of $1,350,000 on loans #30 and 31 at a price per share of $3.00, or fair value of $1,350,000. Series B Convertible Preferred Stock – Distribution – Related Party On February 13, 2025, immediately prior to the consummation of the common control merger, the Company effectuated a non-cash distribution of 1,400,000 shares of Series B convertible preferred stock to its Chief Executive Officer, a related party. The transaction was executed in fulfillment of a previously established arrangement between the CEO and NextNRG LLC, a wholly owned subsidiary of the Company and former holder of the Series B convertible preferred stock. Under this arrangement, the CEO had advanced personal funds to NextNRG LLC to facilitate the original acquisition of the shares on behalf of the Company. As the transfer settled an internal capital funding obligation and involved no exchange of cash or services at the time of distribution, the transaction was accounted for as a capital contribution by a related party in accordance with ASC 505-10, Equity – Overall, and ASC 850-10, Related Party Disclosures. No gain or loss was recognized, and the Series B shares were recorded at par value, with the offset credited to additional paid-in capital. The CEO meets the definition of a related party under ASC 850-10-20, which includes executive officers and entities under their control. Furthermore, in accordance with SAB Topic 5.G and Regulation S-X Rule 4-08(k), the Company has disclosed this transaction due to the material nature of the capital stock transfer and its occurrence with a related party. This distribution did not impact the determination of net income (loss) available to common stockholders and was excluded from the calculation of earnings per share in accordance with ASC 260-10-45-59, as the issuance represented a capital transaction rather than an income or expense-generating event. Series A and B Convertible Preferred Stock – Preferred Stock Dividends Payable in Common Stock In accordance with the terms of the Company’s Series A convertible preferred stock and the Series B convertible preferred stock, the Company is required to accrue dividends on a quarterly basis. Similar to the Series A and Series B convertible preferred stock, dividends are accrued using a fixed conversion price. There are no other provisions that could result in a variable number of shares required for settlement in the future. Additionally, the Company has considered relevant accounting guidance, and has determined that there are no provisions related to its dividends that would require derivative liability treatment. At June 30, 2025 and December 31, 2024, the Company had accrued dividends totaling $173,438 and $258,271, respectively. In 2025, the Company issued 93,576 shares of common stock to settle the outstanding dividends due and another 62,839 in newly-accrued dividends. The following is a summary of the Company’s dividends: Schedule of Dividends Payable
|  | Series A Convertible Preferred Stock |  | Series B Convertible Preferred Stock |  | Total Dividends Payable
Shares issued and outstanding |  |  | 363,000 |  |  |  | 140,000 |  |  |  |  |
Stated value per share |  | $ | 10 |  |  | $ | 10 |  |  |  |  |
Dividend rate (10%/12%) |  |  | 10 | % |  |  | 12 | % |  |  |  |
Dividend shares due per year |  |  | 363,000 |  |  |  | 168,000 |  |  |  |  |
Market price - at issuance date |  |  | 2.76 |  |  |  | 2.76 |  |  |  |  |
Minimum price - 70%/80% discount to market price |  |  | 80 | % |  |  | 70 | % |  |  |  |
Conversion price |  |  | 2.21 |  |  |  | 1.93 |  |  |  |  |
Dividend shares due per quarter |  |  | 41,101 |  |  |  | 21,739 |  |  |  | 62,840 |
Equivalent common shares - per year |  |  | 164,402 |  |  |  | 86,957 |  |  |  | 251,359 |
The following represents the Company’s Series A and B convertible preferred stock quantity of shares due at June 30, 2025 and December 31, 2024: Schedule of Series A and B Convertible Preferred Stock Dividends Payable
|  | Series A Convertible Preferred Stock |  | Series B Convertible Preferred Stock |  | Total Dividends Payable
December 31, 2024 |  |  | 61,204 |  |  |  | 32,372 |  |  |  | 93,576 |
Dividends payable, shares |  |  | 61,204 |  |  |  | 32,372 |  |  |  | 93,576 |
Accrued dividends payable - Series A and Series B convertible preferred stock |  |  | 82,200 |  |  |  | 43,478 |  |  |  | 62,840 |
Accrued dividends payable |  |  | 82,200 |  |  |  | 43,478 |  |  |  | 62,840 |
Payment of accrued dividends as common stock |  |  | (102,304 | ) |  |  | (54,111 | ) |  |  | (156,414 | )
Payment of accrued dividends as common stock, shares |  |  | (102,304 | ) |  |  | (54,111 | ) |  |  | (156,414 | )
June 30, 2025 |  |  | 41,100 |  |  |  | 21,739 |  |  |  | 62,839 |
Dividends payable, shares |  |  | 41,100 |  |  |  | 21,739 |  |  |  | 62,839 |
The following represents the Company’s Series A and B convertible preferred stock valuation due at June 30, 2025 and December 31, 2024:
|  | Series A Convertible Preferred Stock |  |  | Series B Convertible Preferred Stock |  |  | Total Dividends Payable |
December 31, 2024 |  | $ | 168,923 |  |  | $ | 89,348 |  |  | $ | 258,271 |
Dividends payable |  | $ | 168,923 |  |  | $ | 89,348 |  |  | $ | 258,271 |
Accrued dividends payable - Series A and Series B convertible preferred stock |  |  | 226,876 |  |  |  | 120,000 |  |  |  | 346,876 |
Payment of accrued dividends as common stock |  |  | (340,314 | ) |  |  | (149,348 | ) |  |  | (489,662 | )
June 30, 2025 |  | $ | 113,438 |  |  | $ | 60,000 |  |  | $ | 173,438 |
Dividends payable |  | $ | 113,438 |  |  | $ | 60,000 |  |  | $ | 173,438 |
Equity Transactions for the Year Ended December 31, 2024 and the Six Months Ended June 30, 2025 Vesting of Board of Director Common Stock Grants – Related Parties The Company issued 88,336 shares of common stock (par value of $9) in connection with the vesting of shares previously granted in 2023 to various board members. The issuance of these shares had no net effect of stockholders’ deficit as the share issuance was reflected at par value. The Company recorded $251,334 of expense in 2024, related to the vesting of these shares in 2024. The Company issued 136,484 shares of common stock to various board members for services rendered in 2024, having a fair value of $520,000 ($3.81/share), based upon the quoted closing trading price. Total share-based payments to board members in 2024 were $771,334. Also, see Note 7 for the expense recorded in 2024 of $34,666 related to the vesting of shares for the Company’s Chief Technology Officer. Total share-based payments (including vesting of prior period awards) with board members and officers for the year ended December 31, 2024 totaled $806,000. Stock Issued for Services The Company issued 212,730 shares of common stock to consultants for services rendered, having a fair value of $725,640 ($0.0001 - $3.52/share), based upon the quoted closing trading price. Stock Issued to Settle Accounts Payable The Company issued 2,703 shares of common stock to a vendor for services rendered, having a fair value of $10,000 ($3.70/share), based upon the quoted closing price. Series A Convertible Preferred Stock Issued in Debt Conversion On August 16, 2024, the Company converted all outstanding principal ($2,420,000) and accrued interest ($0) into 363,000 shares of Series A convertible preferred stock at a $10/share stated value. At the time of conversion, the lender executed a 150% penalty interest feature. As a result, and just prior to conversion, the Company increased its interest expense and related debt by $1,210,000 for a total of $3,630,000 of debt that was converted. As a result of this debt conversion, the balance due to this lender was $0 as of June 30, 2025 and December 31, 2024. See Note 5 regarding debt conversion and related loss on debt extinguishment. Restricted Stock and Related Vesting A summary of the Company’s non-vested shares (due to service time-based restrictions) as of June 30, 2025 and December 31, 2024, is presented below: Schedule of Company Nonvested Shares
|  |  |  |  | Weighted Average |
|  | Number of |  |  | Grant Date |
Non-Vested Shares |  | Shares |  |  | Fair Value |
Balance - December 31, 2023 |  |  | 114,336 |  |  |  | 6.40 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (88,336 | ) |  |  | 5.15 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - December 31, 2024 |  |  | 26,000 |  |  | $ | 6.40 |
Granted |  |  | 1,000,000 |  |  |  | 3.18 |
Vested |  |  | 13,000 |  |  |  | 6.40 |
Cancelled/Forfeited |  |  | - |  |  |  | - |
Balance - June 30, 2025 |  |  | 1,039,000 |  |  | $ | 3.22 |
The Company has issued various equity grants to directors, officers, consultants and employees. These grants typically contain a vesting period of one to three years and require services to be performed in order for the shares to vest. The Company determines the fair value of the equity grant on the issuance date based upon the quoted closing trading price. These amounts are then recognized as compensation expense over the requisite service period and are recorded as a component of general and administrative expenses in the accompanying unaudited consolidated statements of operations. The Company recognizes forfeitures of restricted shares as they occur rather than estimating a forfeiture rate. Any unvested share-based compensation is reversed on the date of forfeiture, which is typically due to service termination. At June 30, 2025, unrecognized stock compensation expense related to restricted stock was $1,869,890, which will be recognized over a weighted-average period of one 1 year. During the six months ended June 30, 2025, and 2024, the Company recognized compensation expense of $981,211 and $251,333, respectively, related to the vesting of these shares. Warrants Warrant activity for the three months ended June 30, 2025 and December 31, 2024 are summarized as follows: Schedule of Stock Warrant Activity
|  |  |  |  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Weighted |  |  | Average |  |  |  |
|  |  |  |  | Average |  |  | Remaining |  |  | Aggregate |
|  | Number of |  |  | Exercise |  |  | Contractual |  |  | Intrinsic |
Warrants |  | Warrants |  |  | Price |  |  | Term (Years) |  |  | Value |
Outstanding - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Vested and Exercisable - December 31, 2023 |  |  | 81,452 |  |  | $ | 10.36 |  |  |  | 1.22 |  |  | $ | 36,030 |
Unvested and non-exercisable - December 31, 2023 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  | (35,107 | ) |  | $ | 17.28 |  |  |  | - |  |  |  | - |
Outstanding - December 31, 2024 |  |  | 46,345 |  |  | $ | 5.12 |  |  |  | 0.65 |  |  | $ | 9,156 |
Vested and Exercisable - December 31, 2024 |  |  | 46,345 |  |  | $ | 5.12 |  |  |  | 0.65 |  |  | $ | 9,156 |
Unvested and non-exercisable - December 31, 2024 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | 250,000 |  |  | $ | 3.75 |  |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Cancelled/Forfeited |  |  | (19,062 | ) |  | $ | 4.37 |  |  |  | - |  |  |  | - |
Outstanding - June 30, 2025 |  |  | 277,282 |  |  | $ | 3.94 |  |  |  | 4.33 |  |  | $ | - |
Vested and Exercisable - June 30, 2025 |  |  | 277,282 |  |  | $ | 3.94 |  |  |  | 4.33 |  |  | $ | - |
Unvested and non-exercisable - June 30, 2025 |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration